Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Alnylam Pharmaceuticals Inc ALNY

Sector: Healthcare | Sub-Sector: Biotechnology

Alnylam Pharmaceuticals Inc is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Price: $68.47 | Change: $-1.20 | %Change: -1.72%
Volume: 417,621 | Day High/Low: 69.77/67.58 | 52 Week High/Low: 112.57/47.03

Snapshot

Last Traded: September 02, 2014 12:00 Transaction Volume: 417,621
Open: $68.47 Previous Close: $69.67
Bid: $68.00 Ask: $68.69
Bid Size: 200 Ask Size: 100
Market Cap: $5.2b Shares Out: 76.4m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • Stepping up today

    0 stars

    I am getting my feet wet in this as I believe it is on the threshold of some exciting developments with respect to 'RNA Interference...

    2.5 stars


  • ALNY Short Squeeze

    0 stars

    With the press release today, there's a squeeze happening with the ALNY short-sellers.  Volume has hit approximately 3.5 million today...

    1.5 stars


  • Bought last week

    0 stars

    Alnylam announced last Tuesday that it has filed to sell 7.5 million shares of common stock at $10.75 a share, with the intent of raising...

    0 stars


  • Not gonna be good ALNY

    0 stars

    TKM gets an injunction from BC coutrs for alleged documents pilfered from TKM computer files. Wil carry substantial wieght IMO in the...

    2 stars


  • Tekmira receives milestone payments for ALN-TTR01

    0 stars

    Tekmira receives milestone payments of up to US$16 from Alnylam for TTR01...From Tekmira Website:"Alnylam has broad access to Tekmira’s...

    2.5 stars